Adapting to change: The challenge of HIV vaccine development

Science Communicator Emerson Gaglardi blogs on Science Borealis about vaccines, the challenges of HIV vaccine development and his interview with Dr. Pantophlet about exciting research in the Pantophlet Lab in their efforts to develop an effective HIV vaccine formulation.

[article] [PDF]

Publications of the Week – Profile on Science in the City of Nature Communications publication

Our paper on a synthetic mimic of mammalian oligomannose is now out! It appears in the journal Nature Communications. Here is coverage of the paper on Vancouver’s Science in the City.

[article] [PDF]

 

Canada’s top student scientist recognized at Sanofi Biogenius Canada national final

Iva Demirova wins first place at the national final of the Sanofi Biogenius Canada (SBC) competition for her research work conducted in the Pantophlet Lab. The competition and awards ceremony took place in Ottawa on May 2 and 3, 2016. Iva is a grade 11 International Baccalaureate (IB) student from New Westminster Secondary School in BC.

SFU researchers help discover new HIV vaccine-related tool

Media release by SFU News of our discovery, published in Chemistry & Biology (now termed Cell Chemical Biology), of a generally harmless bacterium, Rhizobium radiobacter, that on its surface carries sugar molecules that resemble those on the surface of HIV imparted by the mammalian host cell. The discovery of these bacterial sugar molecules could help in the development of a vaccine against this still important virus.

[article] [PDF]

Breakthrough raises hope for AIDS vaccine

Dr. Pantophlet and other HIV researchers comment on the discovery of the PG9 and PG16 broadly neutralizing antibodies reported recently in the journal Science.

[article] [PDF]